Revenue (Quarterly) Chart

View Revenue (Quarterly) for SERA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 0.03M
March 31, 2026 0.014M
December 31, 2025 0.01M
September 30, 2025 0.016M
June 30, 2025 0.017M
March 31, 2025 0.038M
December 31, 2024 0.024M
September 30, 2024 0.029M
June 30, 2024 0.024M
March 31, 2024 0.00
December 31, 2023 0.041M
September 30, 2023 0.042M
June 30, 2023 0.123M
Date Value
March 31, 2023 0.10M
December 31, 2022 0.065M
September 30, 2022 0.087M
June 30, 2022 0.078M
March 31, 2022 0.038M
December 31, 2021 0.026M
September 30, 2021 0.023M
June 30, 2021 0.02M
March 31, 2021 0.013M
December 31, 2020 0.006M
September 30, 2020 0.005M
June 30, 2020 0.006M
March 31, 2020 0.008M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 190.70M
BioRestorative Therapies, Inc. 0.0232M
CareDx, Inc. 131.95M
Natera, Inc. 752.75M
Exagen, Inc. 19.94M